Amedisys Profit Margin 2010-2024 | AMED

Current and historical gross margin, operating margin and net profit margin for Amedisys (AMED) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Amedisys net profit margin as of September 30, 2024 is 3.57%.
Amedisys Annual Profit Margins
Amedisys Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.017B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.312B 0.00
Quest Diagnostics (DGX) United States $18.153B 18.23
DaVita (DVA) United States $14.110B 18.25
Encompass Health (EHC) United States $9.934B 22.26
Chemed (CHE) United States $8.335B 25.62
Elanco Animal Health (ELAN) United States $5.917B 14.08
Option Care Health (OPCH) United States $5.245B 24.85
RadNet (RDNT) United States $4.764B 105.51
LifeStance Health (LFST) United States $3.053B 0.00
Addus HomeCare (ADUS) United States $2.171B 25.48
Astrana Health (ASTH) United States $2.001B 27.37
U.S Physical Therapy (USPH) United States $1.324B 34.81
Aveanna Healthcare Holdings (AVAH) United States $0.935B 0.00
Pennant (PNTG) United States $0.935B 37.81
Atai Life Sciences (ATAI) Germany $0.356B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00